Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flanagan

Showing results (141-150 of 840) with videos related to

Pageof 84
Sort By:
Annals of the New York Academy of Sciences|February 13, 1996
Breaking of oral tolerance by an encapsulated antigenM Flanagan, S Jain, J G Michael
Calcified Tissue International|April 1, 1996
Casodex (a nonsteroidal antiandrogen) reduces cancellous, endosteal, and periosteal bone formation in estrogen-replete female ratsC Lea, N Kendall, A M Flanagan
Surgical Pathology Clinics|November 7, 2021
Benign Bone-Forming TumorsFernanda Amary, Adrienne M Flanagan, Paul O'Donnell
Surgical Pathology Clinics|November 7, 2021
Notochordal TumorsRoberto Tirabosco, Paul O'Donnell, Adrienne M Flanagan
Cell Death and Differentiation|October 12, 2023
(B)On(e)-cohistones and the epigenetic alterations at the root of bone cancerPaolo Salomoni, Adrienne M Flanagan, Lucia Cottone
American Journal of Hematology|March 14, 2026
Genetics and Genomics in Sickle Cell Disease in AfricaSiana Nkya, Julie Makani, Jonathan M Flanagan
Biochemistry|August 3, 1982
Biosynthesis, nonenzymatic synthesis, and purification of the intermediate in synthesis of sepiapterin in DrosophilaD Dorsett, J M Flanagan, K B Jacobson
Cell|December 9, 1997
The structure of ClpP at 2.3 A resolution suggests a model for ATP-dependent proteolysisJ Wang, J A Hartling, J M Flanagan
Journal of Clinical Pathology|December 22, 1999
Extension of extramammary Paget disease of the vulva to the cervixJ Lloyd, D J Evans, A M Flanagan
Nucleic Acids Research|August 1, 1996
Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potencyW M Flanagan, A Kothavale, R W Wagner
Pageof 84

Showing results (141-150 of 840) with videos related to

Sort By:
Pageof 84
Annals of the New York Academy of Sciences|February 13, 1996
Breaking of oral tolerance by an encapsulated antigenM Flanagan, S Jain, J G Michael
Calcified Tissue International|April 1, 1996
Casodex (a nonsteroidal antiandrogen) reduces cancellous, endosteal, and periosteal bone formation in estrogen-replete female ratsC Lea, N Kendall, A M Flanagan
Surgical Pathology Clinics|November 7, 2021
Benign Bone-Forming TumorsFernanda Amary, Adrienne M Flanagan, Paul O'Donnell
Surgical Pathology Clinics|November 7, 2021
Notochordal TumorsRoberto Tirabosco, Paul O'Donnell, Adrienne M Flanagan
Cell Death and Differentiation|October 12, 2023
(B)On(e)-cohistones and the epigenetic alterations at the root of bone cancerPaolo Salomoni, Adrienne M Flanagan, Lucia Cottone
American Journal of Hematology|March 14, 2026
Genetics and Genomics in Sickle Cell Disease in AfricaSiana Nkya, Julie Makani, Jonathan M Flanagan
Biochemistry|August 3, 1982
Biosynthesis, nonenzymatic synthesis, and purification of the intermediate in synthesis of sepiapterin in DrosophilaD Dorsett, J M Flanagan, K B Jacobson
Cell|December 9, 1997
The structure of ClpP at 2.3 A resolution suggests a model for ATP-dependent proteolysisJ Wang, J A Hartling, J M Flanagan
Journal of Clinical Pathology|December 22, 1999
Extension of extramammary Paget disease of the vulva to the cervixJ Lloyd, D J Evans, A M Flanagan
Nucleic Acids Research|August 1, 1996
Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potencyW M Flanagan, A Kothavale, R W Wagner
Pageof 84